Joshua T. Kantrowitz - Publications, H-index & Citations

Joshua T. Kantrowitz

New York State Psychiatric Institute

38H指数

124论文数

4.9K被引数

收录论文 72

发表时间

Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis 5-HT3R拮抗剂对精神分裂症阴性症状和认知障碍的疗效：系统评价与荟萃分析

Neuropsychopharmacology

IF7.1

2026-06-17

PREAI

Megan R. Mayer; Tse-Hwei Choo; Daniel C. Javitt; Joshua T. Kantrowitz

A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study 鲁瓦达克西STAT在治疗伴有认知障碍的精神分裂症成人中的2期随机对照试验：ERUDITE研究的结果

Neuropsychopharmacology

IF7.1

2026-04-24

OAAI

Ni A. Khin; Reuben H. Fan; Tingting Ge; Hans S. Klein; Jacob S. Ballon; Satjit Brar; Philip D. Harvey; Joshua T. Kantrowitz; Richard S. E. Keefe; Mahnaz Asgharnejad; Venkatesha Murthy; Eiry Roberts; Jaskaran B. Singh

Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study 数字疗法对精神分裂症体验性阴性症状的可行性：一项探索性研究的结果

Schizophrenia

IF4.1

2025-09-26

OAAI

Haig Goenjian; Abhishek Pratap; Cassandra Snipes; Brendan D. Hare; Joshua T. Kantrowitz; Tshekedi Dennis; Wakelin McNeel; Eehwa Ung; Olya Besedina; Alankar Gupta; Tim Campellone; Mariya Petrova; Sergio Perocco; Uma Vaidyanathan; Shaheen E. Lakhan; Cornelia Dorner-Ciossek

Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study 评估Schizophrenia Cognition Rating Scale的评分者间信度：一项非干预性定量研究

SCHIZOPHRENIA

IF4.1

2025-04-28

OAAI

Tulliez, Sebastien; Karantzoulis, Stella; Marcus, James C.; Casamayor, Montserrat; Blanchard, Cassie; Goenjian, Haig; Kantrowitz, Joshua T.; Shirikjian, Lara; Sonnenberg, John; Reuteman-Fowler, Corey; Harvey, Philip D.; Keefe, Richard S. E.

RECENT ADVANCES IN TARGET ENGAGEMENT STUDIES IN SCHIZOPHRENIA 精神分裂症靶点参与研究的最新进展

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

IF3.7

2025-02-12

OAAI

Kantrowitz, Joshua T.; Iosifescu, Daniel; Grinband, Jack; Sehatpour, Pejman; Mayer, Megan R.; Javitt, Daniel C.

Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape 精神分裂症的阴性症状：关于研究评估和当前及未来治疗格局的更新

CNS DRUGS

IF7.4

2025-01-12

PREAI

Govil, Preetika; Kantrowitz, Joshua T.

Knowing is Half the Battle: The Factors Leading to Efficient Recruitment of Representative Samples in Schizophrenia Research

PHARMACEUTICAL MEDICINE

IF4.5

2025-01-11

PREAI

Yoon, Joohyun; Mayer, Megan R.; Berro, Tala; Brazis, Stephanie; Kantrowitz, Joshua T.

Finding the Right Dose: NMDA Receptor- Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement

BIOLOGICAL PSYCHIATRY

IF9

2025-01-01

PREAI

Sehatpour, Pejman; Kantrowitz, Joshua T.

Augmentation of learning in schizophrenia by D-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study

SCHIZOPHRENIA RESEARCH

IF3.5

2023-10-01

OAAI

Govani, Viraj; Shastry, Adithya M.; Iosifescu, Dan V.; Govil, Preetika; Mayer, Megan R.; Sobeih, Tarek; Choo, Tse-Hwei; Wall, Melanie M.; Sehatpour, Pejman; Kantrowitz, Joshua T.

Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo- Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist D-serine

BIOLOGICAL PSYCHIATRY

IF9

2023-07-01

OAAI

Sehatpour, Pejman; Iosifescu, Dan V.; De Baun, Heloise M.; Shope, Constance; Mayer, Megan R.; Gangwisch, James; Dias, Elisa; Sobeih, Tarek; Choo, Tse-Hwei; Wall, Melanie M.; Medalia, Alice; Saperstein, Alice M.; Kegeles, Lawrence S.; Girgis, Ragy R.; Carlson, Marlene; Kantrowitz, Joshua T.

Illness Phase as a Key Assessment and Intervention Window for Psychosis

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE

IF3.7

2023-07-01

OAAI

Kohler, Christian G.; Wolf, Daniel H.; Abi-Dargham, Anissa; Anticevic, Alan; Cho, Youngsun T.; Fonteneau, Clara; Gil, Roberto; Girgis, Ragy R.; Gray, David L.; Grinband, Jack; Javitch, Jonathan A.; Kantrowitz, Joshua T.; Krystal, John H.; Lieberman, Jeffrey A.; Murray, John D.; Ranganathan, Mohini; Santamauro, Nicole; Van Snellenberg, Jared X.; Gur, Ruben C.; Gur, Raquel E.; Calkins, Monica E.

Early auditory processing dysfunction in schizophrenia: Mechanisms and implications

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2023-05-01

OAAI

Donde, Clement; Kantrowitz, Joshua T.; Medalia, Alice; Saperstein, Alice M.; Balla, Andrea; Sehatpour, Pejman; Martinez, Antigona; O'Connell, Monica N.; Javitt, Daniel C.

Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

SCHIZOPHRENIA BULLETIN

IF4.8

2022-07-12

OAAI

Adam, Ondine; Blay, Martin; Brunoni, Andre R.; Chang, Hsin-An; Gomes, July S.; Javitt, Daniel C.; Jung, Do-Un; Kantrowitz, Joshua T.; Koops, Sanne; Lindenmayer, Jean-Pierre; Palm, Ulrich; Smith, Robert C.; Sommer, Iris E.; Lane Valiengo, Leandro do Costa; Weickert, Thomas W.; Brunelin, Jerome; Mondino, Marine

Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058

NEUROPSYCHOPHARMACOLOGY

IF7.1

2021-10-20

OAAI

Sehatpour, Pejman; Javitt, Daniel C.; De Baun, Heloise M.; Carlson, Marlene; Beloborodova, Anna; Margolin, David H.; Carlton, Mark B. L.; Brice, Nicola L.; Kantrowitz, Joshua T.

Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions

CNS DRUGS

IF7.4

2021-10-15

PREAI

Kantrowitz, Joshua T.

Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia

SCHIZOPHRENIA BULLETIN

IF4.8

2021-08-23

OAAI

Abi-Dargham, Anissa; Javitch, Jonathan A.; Slifstein, Mark; Anticevic, Alan; Calkins, Monica E.; Cho, Youngsun T.; Fonteneau, Clara; Gil, Roberto; Girgis, Ragy; Gur, Raquel E.; Gur, Ruben C.; Grinband, Jack; Kantrowitz, Joshua; Kohler, Christian; Krystal, John; Murray, John; Ranganathan, Mohini; Santamauro, Nicole; Van Snellenberg, Jared; Tamayo, Zailyn; Wolf, Daniel; Gray, David; Lieberman, Jeffrey

D-Serine: A Cross Species Review of Safety

FRONTIERS IN PSYCHIATRY

IF3.2

2021-08-10

OAAI

Meftah, Amir; Hasegawa, Hiroshi; Kantrowitz, Joshua T.

Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder 无药物治疗的重度抑郁症患者的腹内侧前额叶皮层/前扣带回皮层Glx，谷氨酸和GABA水平

TRANSLATIONAL PSYCHIATRY

IF6.2

2021-08-05

OAAI

Kantrowitz, Joshua T.; Dong, Zhengchao; Milak, Matthew S.; Rashid, Rain; Kegeles, Lawrence S.; Javitt, Daniel C.; Lieberman, Jeffrey A.; Mann, J. John

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study

FRONTIERS IN PSYCHIATRY

IF3.2

2021-06-02

OAAI

Dong, Zhengchao; Grunebaum, Michael F.; Lan, Martin J.; Wagner, Vashti; Choo, Tse-Hwei; Milak, Matthew S.; Sobeih, Tarek; Mann, J. John; Kantrowitz, Joshua T.

Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia

FRONTIERS IN PSYCHIATRY

IF3.2

2021-02-02

OAAI

Sehatpour, Pejman; Avissar, Michael; Kantrowitz, Joshua T.; Corcoran, Cheryl M.; De Baun, Heloise M.; Patel, Gaurav H.; Girgis, Ragy R.; Brucato, Gary; Lopez-Calderon, Javier; Silipo, Gail; Dias, Elisa; Martinez, Antigona; Javitt, Daniel C.

研究方向